Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells.

Increased proliferation of human synovial mesen- chymal stem cells with autologous human serum: compari- sons with bone marrow mesenchymal stem cells and with fetal bovine serum.

In order to evaluate the percentage of cancer stem cells in the total HepG2 cell population following exposure to low-dose cisplatin, cells were labeled with the cancer stem

Specific genes that are predominantly expressed or exclusively expressed in prostate cells, prostate cancer cells, and prostate metastasis cells at the level of DNA, RNA and

Silvers et al., “Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer,” The Prostate , vol.

Ficusonic acid ( 1 ) was tested against two cancer cell lines, HeLa (cervical cancer cells) and PC-3 (prostate cancer cells) for its antiproliferative activity along with three

Here, we have sorted HCC cells using CD133 as a cancer stem cell (CSC) marker by magnetic-activated cell sorting (MACS) and demonstrated that the CD133 + HCC cells not only

In aggressive breast cancer cell lines, a cell population with high ALDH activity as assessed by the Aldefluor assay has been shown to be enriched in tumorigenic stem/progenitor

Hypoxic treatment also induced growth capability of CD44 positive cells in these two cell lines, and CD44 bright cells possessed greater stem cell-like features, as verified by